Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Rajiv Mundayat"'
Autor:
Philip J. Mease, Pamela Young, Lara Fallon, Rajiv Mundayat, Oluwaseyi Dina, Taylor Blachley, Nicole Middaugh, Alexis Ogdie
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 2, Pp 313-329 (2024)
Abstract Introduction Randomized controlled trials have demonstrated tofacitinib efficacy for psoriatic arthritis (PsA); however, real-world effectiveness data are limited. This real-world analysis assessed baseline demographics/disease characteristi
Externí odkaz:
https://doaj.org/article/7cf6d725968f442b82ef8a79b8f60232
Autor:
Philip J. Mease, Ana-Maria Orbai, Oliver FitzGerald, Mohamed Bedaiwi, Dona L. Fleishaker, Rajiv Mundayat, Pamela Young, Philip S. Helliwell
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-13 (2023)
Abstract Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This post hoc analysis assessed tofacitinib efficacy on enthesitis by baseline location and severity, and impact on disease activity and
Externí odkaz:
https://doaj.org/article/f0a17b04c72145eab9ba293da31833b6
Autor:
David T. Rubin, Leonardo Salese, Mitchell Cohen, Paulo G. Kotze, John C. Woolcott, Chinyu Su, Rajiv Mundayat, Jerome Paulissen, Joana Torres, Millie D. Long
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: Tofacitinib is an oral small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Objective: To assess colectomy incidence rates (IRs) and baseline characteristics for the presence of identified colectomy risk fac
Externí odkaz:
https://doaj.org/article/4f14d6481d204724942026dae5b142a5
Autor:
Ana-Maria Orbai, Philip J. Mease, Philip S. Helliwell, Oliver FitzGerald, Dona L. Fleishaker, Rajiv Mundayat, Pamela Young
Publikováno v:
BMC Rheumatology, Vol 6, Iss 1, Pp 1-12 (2022)
Abstract Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This post-hoc analysis of two phase III studies in patients with PsA treated with tofacitinib assessed dactylitis by location, and the i
Externí odkaz:
https://doaj.org/article/fd02bbe68645406c8131109f93801616
Autor:
David T. Rubin, Walter Reinisch, Thomas Greuter, Paulo G. Kotze, Marcia Pinheiro, Rajiv Mundayat, Eric Maller, Marc Fellmann, Nervin Lawendy, Irene Modesto, Stephan R. Vavricka, Gary R. Lichtenstein
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Introduction: Extraintestinal manifestations (EIMs) in patients with ulcerative colitis (UC) are common. Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of UC. We evaluated the efficacy of tofacitinib in patients with
Externí odkaz:
https://doaj.org/article/e097ca53b86849d19e2e7355909c6a94
Autor:
Daniela Graham, Christopher Ritchlin, Jon T Giles, Juan J Gomez Reino, Philip Helliwell, Pamela Young, Wael Joseph, Rajiv Mundayat
Publikováno v:
RMD Open, Vol 7, Iss 1 (2021)
Objectives This post-hoc analysis explored the impact of body mass index (BMI) on tofacitinib efficacy/safety in patients with active psoriatic arthritis (PsA).Methods Data were pooled from two phase 3 studies (NCT01877668; NCT01882439). Analyses inc
Externí odkaz:
https://doaj.org/article/8fdeb69b5f6f4eb9b2ab37d9bcf0083f
Autor:
Arnt V Kristen, Mathew S Maurer, Claudio Rapezzi, Rajiv Mundayat, Ole B Suhr, Thibaud Damy, THAOS investigators
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0173086 (2017)
AIM:Cardiac troponins and natriuretic peptides are established for risk stratification in light-chain amyloidosis. Data on cardiac biomarkers in transthyretin amyloidosis (ATTR) are lacking. METHODS AND RESULTS:Patients (n = 1617) with any of the fol
Externí odkaz:
https://doaj.org/article/d939601c64bf48cb85a1781472ed61ae
Autor:
Márcia Waddington Cruz, Marcus Vinicius Pinto, Luiz Felipe Pinto, Renata Gervais, Moisés Dias, Carlos Perez, Rajiv Mundayat, Moh-Lim Ong, Roberto Coury Pedrosa, Débora Foguel
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 77, Iss 2, Pp 96-100
ABSTRACT Transthyretin amyloidosis (ATTR) is characterized by the deposit of mutant or wild-type transthyretin that forms amyloid fibrils, which are extracellularly deposited within tissues and organs. Clinical manifestations of familial amyloid poly
Externí odkaz:
https://doaj.org/article/3cad4dfa144444e488dbf76795a0c821
Autor:
David P. Hudesman, Joana Torres, Leonardo Salese, John C. Woolcott, Rajiv Mundayat, Chinyu Su, Mahmoud H. Mosli, Jessica R. Allegretti
Publikováno v:
The Patient - Patient-Centered Outcomes Research. 16:95-103
Autor:
Remo Panaccione, Maria T. Abreu, Irina Lazariciu, Rajiv Mundayat, Nervin Lawendy, Leonardo Salese, John C. Woolcott, Bruce E. Sands, María Chaparro
Publikováno v:
Alimentary Pharmacology & Therapeutics. 55:1534-1544
Tofacitinib is an oral Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Aim:This post hoc analysis evaluated tofacitinib persistence in patients with UC in OCTAVE Open, an open-label, long-term extension study of patients receivin